Avid Bioservices Inc (CDMO)

[biopharm]

Moving along nicely but we have not heard of all the shenanigans in the background surrounding PS Targeting IP ...things will be coming as Kyla Driscoll involved in PS Targeting

Quote:
June 14 2018

Todays guest blog comes from Kyla Driscoll, Ph.D., senior research advisor and group leader focused on Lillys immuno-oncology drug discovery and development and Emily Collins, Ph.D., senior director of imaging research and development working across the Lilly portfolio including Lillys pain portfolio. Kyla and Emily recently traveled to Washington, D.C. with their Lilly colleague Jirong Lu, Ph.D., to talk about their work with Members of Congress and Capitol Hill staff. Here is a recap of their trip, in their own words.

https://lillypad.lilly.com/entry.php?e=10976

_________

If the late Dr Phil Thorpe or Ruth Lilly ever seen some of the greed going on to bring us closer to historic medical advances...I would say disgraced they would be.

Looks like we are ever closer and as usual.... who will Trump the news of big PS Targeting Alzheimer's news...instead of Biden time and slow playing things.....maybe Roche gets a bit antsy now and just can't sit back no longer ( hopefully someone notices that Driscoll sits in NY much these days and Oncologie has Ex Eli Lilly Bronislaw (Bronek) Pytowski Senior Director, Non-clinical research at Oncologie, Inc.
Oncologie, Inc. that must .....be some interesting conversations ...but not as much as Alex Azar ( remember the Azars are well placed in Indiana and KNOW Eli Lilly well

_______

Kyla Driscoll

Chief Scientific Officer, Immuno-Oncology at Eli Lilly and Company
Eli Lilly and Company
Drew University
Greater New York City Area
500+ connections

Experience
Eli Lilly and Company
11 years
Chief Scientific Officer, Immuno-Oncology
Oct 2019 â?? Present 2 months
New York, New York

Research Fellow
Oct 2018 â?? Oct 2019 1 year 1 month
...
...

__________


10 Things You Didn't Know About Alex Azar

Katelyn Newman â?¢ Jan. 29, 2018, at 2:22 p.m.

1. Alex Michael Azar II was born on June 17, 1967, in Johnstown, Pennsylvania.

2. Azar spent five years, from 2012 to 2017, as the president of Lilly USA, LLC, a biopharmaceutical company and affiliate to global leader Eli Lilly and Company. Critics are keen to know if he will lower drug prices or remain tied to his old business practices.

3. Azar graduated summa cum laude with a degree in government and economics from Dartmouth College in 1988. He received his law degree from Yale University.

4. After law school, he served as a law clerk under late Supreme Court Justice Antonin Scalia from 1992 to 1993.


5. Azar moved on to work for Kenneth Starr as an Associate Independent Counsel from 1994 to 1996, where he primarily worked on the Whitewater investigation.

6, Azar was on President George W. Bush's legal team during the contentious Florida recount case following the 2000 presidential election, according to USA Today.

7. Falling into the health industry "by accident," Azar then served as general counsel to the Department of Health and Human Services under then-Secretary Tommy Thompson during Bush's first term in office. He was promoted by Secretary Mike Leavitt to Deputy Secretary of the department during Bush's second term.

8. A conservative Republican, Azar is anti-abortion. In a written response to a question by Sen. Patty Murray, D-Wash., about the department's strategic plan issued in October that promoted fetal personhood, Azar said, "The mission of HHS is to enhance the health and well-being of all Americans, and this includes the unborn."


9. He is the second Health and Human Services secretary to serve under the Trump administration in 11 months. His predecessor Tom Price resigned from office in September amid an investigation into his use of taxpayers' money to fly in expensive private planes for official and personal business.

10. He lives in Indianapolis with his wife, Jennifer, and two children. He is on the board of the Indianapolis Symphony Orchestra.


https://www.usnews.com/news/national-news/articles/2018-01-29/10-things-you-didnt-know-about-alex-azar?context=amp

__________


Alex Azar - BIG Ties Eli Lilly and now...NOW ...hopefully many begin to see the big picture, as CEO Laura Benjamin ties Eli Lilly to Omeros publishing data ( and more being presented at upcoming medical conference ) based on PS Targeting with ties to Eli Lilly etc etc

_________

Kyla Driscoll now just promoted to CSO at Eli Lilly and and certainly...that is done for a PS Targeting reason ....more to come but want you to digest all this slowly...

_________

https://www.researchgate.net/scientific-contributions/38440419_Bronislaw_Pytowski/amp


Significance and Molecular Regulation of Lymphangiogenesis in Cancer

October 2019
with 26 Reads

Cite this publication
Mihaela Skobe at Icahn School of Medicine at Mount Sinai

Mihaela Skobe

Bronislaw Pytowski

...
...
....

Anti-VEGFR2 therapy delays growth of preclinical pediatric tumor models and enhances anti-tumor activity of chemotherapy

September 2019
with 3 Reads

Caitlin D Lowery

Wayne Blosser at Eli Lilly

Michele Dowless at Eli Lilly

Matthew Renschler

Lisa V Perez

Jennifer Stephens

Bronislaw Pytowski

Heather Wasserstrom

Louis F Stancato

Beverly Falcon

....
...
...


Significance and Molecular Regulation of Lymphangiogenesis in Cancer

January 2019
with 36 Reads

Mihaela Skobe at Icahn School of Medicine at Mount Sinai

Bronislaw Pytowski

...
...

https://www.researchgate.net/scientific-contributions/38440419_Bronislaw_Pytowski/amp

______

Methodist Research Institute and Eli Lilly human tissues research for translational medicine NOW shows PS Targeting is of astronomical value and Ruth Lilly would want the truth out, even if it meant that PS Targeting is required ....as ex Eli Lilly folks at Omeros KNOW and what would Ruth have done knowing all this and having some slime John Springs Stafford ...lie, it seems ...to Peregrine Pharmaceuticals now know as Avid Bioservices ...hmm

Maybe Eli Lilly should just make Avid Bioservices part of Avid RadioPharmaceuticals ...heck, I am sure Ampersand Capital would lend Avid CDMO the money to buy out Avid Radio....as long as Ampersand is allowed to magically appear another CDMO as greed masters they are